In this paper, we have demonstrated that RGZ improved hepatic steatosis, accompanied by an elevation in adiponectin, Sirt6 and its related targets, as well as AMPK phosphorylation, both in vivo and in vitro. The gene discussed is ADIPOQ; the disease is Hepatic steatosis.